Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Streetwise Reports (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Canadian Mining Co. to Acquire 99.1% of Copper Mine in Peru

% of readers think this story is Fact. Add your two cents.


Source: Matthew O’Keefe 12/22/2025

Rio2 Ltd. (RIO:TSX; RIOFF:OTCQX; RIO:BVL) will gain the Condestable project and its 45,000-hectare property for total consideration of US$217 million, noted a Cantor Fitzgerald report. Find out why Cantor changed its rating on Rio2.

Rio2 Ltd. (RIO:TSX; RIOFF:OTCQX; RIO:BVL) entered a definitive agreement with Southern Peaks Mining L.P., a private company, to acquire its 99.1% interest in the Condestable copper mine in Peru, reported Cantor Fitzgerald Analyst Matthew O’Keefe in a Dec. 9 research note. Cantor changed its rating on the Canadian mining company to Hold “on price appreciation.”

“We are not overly enamored with the deal given the sparse details provided on the asset, questionable timing (Fenix is not yet complete), and the reduced leverage to precious metals it brings (this may cap the multiple),” O’Keefe wrote. Fenix is Rio2′s flagship asset.

Target Price Maintained

Cantor Fitzgerald maintained its target price on the explorer-developer of CA$2.50 per share (CA$2.50/share) and will wait to revise it until after the deal closes, and more details become available, O’Keefe wrote. He expects the new target will “be largely neutral to net asset value.”

Rio2 was trading at the target price at the time of the analyst’s report. As such, the target implies zero upside.

The company has 429.9 million shares outstanding. Its market cap is CA$1.1 billion. Its 52-week range is CA$0.58–2.51/share.

Financing for Acquisition

The total consideration for Condestable is US$217 million (US$217M), of which US$180M is to be paid upfront and the remaining US$37M to be paid in tranches over four years between 2027 and 2030, noted O’Keefe. Additionally, Rio2 is to assume $24M of net debt. This arrangement implies a transaction enterprise value of US$241M.

To cover the cost of the acquisition, Rio2 arranged a US$185M financing package. It consists of US$65M in vendor debt and a bought-deal equity financing expected to close around Dec. 15. In the upsized equity issue, 74,865,000 subscription receipts of Rio2 will be sold at CA$2.22 apiece, generating total gross proceeds of CA$166M, net CA$120M.

Also, Rio2 entered an agreement with a Peruvian Investment Bank for a private placement for aggregate gross proceeds of up to CA$14M, net CA$10M, through the sale of up to 6,306,300 Rio2 common shares at the issue price.

Rio2′s acquisition of Condestable is expected to close in January 2026.

Expectations of Condestable

Condestable is an underground copper mine about 90 kilometers south of Lima and has been operational since the 1960s, O’Keefe described. Currently, the mine feeds an 8,400 ton per day (8.4 Ktpd) processing plant. It yields a clean concentrate with minor silver and gold byproducts on which Franco-Nevada Corp. (FNV:TSX; FNV:NYSE) appears to have a stream.

“While Condestable is a producing asset, it is an old mine that will likely require significant capital to maintain and extend/expand production as contemplated by Rio2,” the analyst added.

According to Rio2, the mine is projected to produce 27,000 tons per annum (27 Ktpa) of copper equivalent, 80,000 ounces (80 Koz) on a gold equivalent basis, with a 10-year reserve life. No actual resource estimate was provided with the acquisition announcement, but Rio2 indicated it soon will post the April 2024 NI 43-101 technical report on Condestable.

Rio2 expects the project, at spot prices, to generate an average annual EBITDA of US$145M over the next five years. Further, there is potential to expand underground mining capacity to 12 Ktpd, potential for open-pit development, and potential for exploration upside at the 45,000-hectare property.

Update on Fenix Project

O’Keefe reported the status of and plans for Fenix. With construction about 80% done as of Nov. 30, the project is on track and on budget for first gold production in January 2026, noted Rio2. It expects to ramp up production fully to 100 Koz of gold per annum by year-end 2026.

The plan is still in the works to expand Fenix to 80 Ktpd from 20 Ktpd, taking production to 300 Koz of gold annually for about 10 years from 80 Koz. For the expansion, the company intends to complete a prefeasibility study in Q1/26, followed by an update of the Fenix mineral reserve and resource estimate in Q4/26, then completion of a feasibility study in H2/27.

Sign up for our FREE newsletter at: www.streetwisereports.com/get-news

Important Disclosures:

  1. As of the date of this article, officers, contractors, shareholders, and/or employees of Streetwise Reports LLC (including members of their household) own securities of Franco Nevada Corp.
  2. Doresa Banning wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor.
  3. This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.

For additional disclosures, please click here.

Disclosures for Cantor Fitzgerald, Rio2 Ltd., December 9, 2025

The opinions, estimates and projections contained in this report are those of Cantor Fitzgerald Canada Corporation. (“CFCC”) as of the date hereof and are subject to change without notice. Cantor makes every effort to ensure that the contents have been compiled or derived from sources believed to be reliable and that contain information and opinions that are accurate and complete; however, Cantor makes no representation or warranty, express or implied, in respect thereof, takes no responsibility for any errors and omissions which may be contained herein and accepts no liability whatsoever for any loss arising from any use of or reliance on this report or its contents. Information may be available to Cantor that is not herein. This report is provided, for informational purposes only, to institutional investor clients of Cantor Fitzgerald Canada Corporation, and does not constitute an offer or solicitation to buy or sell any securities discussed herein in any jurisdiction where such offer or solicitation would be prohibited. This report is issued and approved for distribution in Canada, CFCC., a member of the Investment Industry Regulatory Organization of Canada (“IIROC”), the Toronto Stock Exchange, the TSX Venture Exchange and the CIPF. This report is has not been reviewed or approved by Cantor Fitzgerald & Co., a member of FINRA. This report is intended for distribution in the United States only to Major Institutional Investors (as such term is defined in SEC 15a-6 and Section 15 of the Securities Exchange Act of 1934, as amended) and is not intended for the use of any person or entity that is not a major institutional investor. Major Institutional Investors receiving this report should effect transactions in securities discussed in the report through Cantor Fitzgerald & Co. Non US Broker Dealer 15a-6 disclosure: This report is being distributed by (CF Canada/CF Europe/CF Hong Kong) in the United States and is intended for distribution in the United States solely to “major U.S. institutional investors” (as such term is defined in Rule15a-6 of the U.S. Securities Exchange Act of 1934 and applicable interpretations relating thereto) and is not intended for the use of any person or entity that is not a major institutional investor. This material is intended solely for institutional investors and investors who Cantor reasonably believes are institutional investors. It is prohibited for distribution to non-institutional clients including retail clients, private clients and individual investors. Major Institutional Investors receiving this report should effect transactions in securities discussed in this report through Cantor Fitzgerald & Co. This report has been prepared in whole or in part by research analysts employed by non-US affiliates of Cantor Fitzgerald & Co that are not registered as broker-dealers in the United States. These non-US research analysts are not registered as associated persons of Cantor Fitzgerald & Co. and are not licensed or qualified as research analysts with FINRA or any other US regulatory authority and, accordingly, may not be subject (among other things) to FINRA’s restrictions regarding communications by a research analyst with a subject company, public appearances by research analysts, and trading securities held by a research analyst account.

Potential conflicts of interest The author of this report is compensated based in part on the overall revenues of Cantor, a portion of which are generated by investment banking activities. Cantor may have had, or seek to have, an investment banking relationship with companies mentioned in this report. Cantor and/or its officers, directors and employees may from time to time acquire, hold or sell securities mentioned herein as principal or agent. Although Cantor makes every effort possible to avoid conflicts of interest, readers should assume that a conflict might exist, and therefore not rely solely on this report when evaluating whether or not to buy or sell the securities of subject companies. Disclosures as of December 9, 2025 Cantor has not provided investment banking services or received investment banking related compensation from Rio2 Limited within the past 12 months. The analysts responsible for this research report do not have, either directly or indirectly, a long or short position in the shares or options of Rio2 Limited. The analyst responsible for this report has not visited the material operations of Rio2 Limited. No payment or reimbursement was received for related travel costs. Analyst certification The research analyst whose name appears on this report hereby certifies that the opinions and recommendations expressed herein accurately reflect his personal views about the securities, issuers or industries discussed herein. Definitions of recommendations BUY: The stock is attractively priced relative to the company’s fundamentals and we expect it to appreciate significantly from the current price over the next 6 to 12 months. BUY (Speculative): The stock is attractively priced relative to the company’s fundamentals, however investment in the security carries a higher degree of risk. HOLD: The stock is fairly valued, lacks a near term catalyst, or its execution risk is such that we expect it to trade within a narrow range of the current price in the next 6 to 12 months. The longer term fundamental value of the company may be materially higher, but certain milestones/catalysts have yet to be fully realized. SELL: The stock is overpriced relative to the company’s fundamentals, and we expect it to decline from the current price over the next 6 to 12 months. TENDER: We believe the offer price by the acquirer is fair and thus recommend investors tender their shares to the offer. UNDER REVIEW: We are temporarily placing our recommendation under review until further information is disclosed. Member-Canadian Investor Protection Fund. Customers’ accounts are protected by the Canadian Investor Protection Fund within specified limits. A brochure describing the nature and limits of coverage is available upon request.

( Companies Mentioned: RIO:TSX;RIOFF:OTCQX;RIO:BVL, )


Source: https://www.streetwisereports.com/article/2025/12/22/canadian-mining-co-to-acquire-99-1-of-copper-mine-in-peru.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login